Clinical Trials: Vomiting

Muscle Shoals : Northwest Alabama Cancer Center

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Muscle Shoals, : Northwest Alabama Cancer Center PC

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Hot Spring : Genesis Cancer Centre

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Burbank : Providence St. Joseph Medical Center

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Corona : Compassionate Cancer Care Center Medical Group

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Fountain Valley : Compassionate Cancer Centre Medical Group

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Mission Hills : Facey Medical Foundation

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Orange : Call for Information (Investigational Site 0014)

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

View More »

Palm Springs : Call for Information (Investigational Site 0021) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Riverside : Compassionate Cancer Care Medical Group

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Riverside : Compassionate Cancer Care Medical Group

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Whittier : Agajanian Institute of Oncology and Hematology

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Aurora : Call for Information (Investigational Site 0001)

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Denver : Denver Health and Hospital Authority

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Washington : Call for Information (Investigational Site 0041)

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Boynton Beach : Palm Beach Institute of Hematology and Oncology

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Jupiter : Call for Information (Investigational Site 0174) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Lakeland : Call for Information (Investigational Site 0035) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Miami : Call for Information (Investigational Site 0042)

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

St. Petersburg : Call for Information (Investigational Site 0012)

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Anderson : Call for Information (Investigational Site 9277) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Evansville : Welborn Clinic

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Evansville : Call for Information (Investigational Site 0020) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

New Albany : Floyd Memorial Cancer Center of Indiana

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Cedar Rapids : Call for Information (Investigational Site 0037) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Hazard : North Shore Medical Center

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Louisville : Call for Information (Investigational Site 0003)

A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)

Rockville : Call for Information (Investigational Site 0036) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Boston : Call for Information (Investigational Site 0020)

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Boston : Call for Information (Investigational Site 0013)

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Waltham : TESARO Inc

A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy

Waltham : TESARO Inc

A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy

Waltham : TESARO Inc

Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy

View More »

Worcester : Fallon Clinic

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

St. Louis : Call for Information (Investigational Site 0043)

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Bronx : Children's Hospital at Montefiore

A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer

Durham : Duke University Medical Center

Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

Winston-Salem : Salem Research Group, Inc.

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Canton : Hematology and Oncology Associates, Inc.

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Canton : Tri-County Hematology & Oncology Associates, Inc

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Pittsburgh : UPMC Magee Women's Hospital

Effectiveness of Aprepitant in the Treatment of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Outpatient Plastic Surgery

Pawtucket : Cancer Center at Memorial Hospital of RI

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Charleston : Charleston Cancer Center

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Columbia : Call for Information (Investigational Site 0031)

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Nashville : Call for Information (Investigational Site 0022)

A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)

Corpus Christi : Cancer Specialists of South Texas, P.A.

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Houston : Call for Information (Investigational Site 0176) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Houston : UT MD Anderson Cancer Center

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Temple : Scott and White Healthcare

Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients

Ogden : Northern Utah Associates [Hematology/ Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Ogden : Northern Utah Associates

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Seattle : Call for Information (Investigational Site 0032) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Spokane : Providence Sacred Heart Medical Center and Children's Hospital

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Tacoma : Northwest Medical Specialties

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Tacoma : Call for Information (Investigational Site 9315) Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Buenos Aires : Merck Sharp & Dohme (Argentina) Inc.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Cordoba : Instituto Oncológico de Córdoba (IONC)

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Mar del Plata : Centro Oncológico Integral (COI)

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Mendoza : Centro Oncologico de Integracion Regional (COIR)

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Quilmes : Instituto Médico CER [Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

View More »

Quilmes B1878DVB : Instituto Médico CER [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Rosario : Sanatorio Parque

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Rosario : Sanatorio Parque

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

San Miguel de Tucuman : Centro Medico San Roque

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

San Miguel de Tucuman : Centro Medico San Roque

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Adelaide SA : RAH Cancer Centre, Royal Adelaide Hospital

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Bobruisk : Bobruisk Interregional Oncological Dispensary

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Brest : Brest Regional Oncological Dispensary

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Gomel : State institution N.N. Alexandrov Republican Scientific and

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Mogilev : Mogilev Regional Oncological Dispensary [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Belo Horizonte : OXION-Medicina Oncológica

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Cachoeiro de Itapemirim : Centro de Pesquisas Clínicas em Oncologia

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Caxias do Sul : IPCEM - Universidade de Caxias do Sul

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Goiânia : Hospital Araújo Jorge

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

ItajaÃ- : ClÃ-nica de Neoplasias do Litoral

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

View More »

Porto Alegre : Hospital Moinhos de Vent

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Rio de Janeiro : Oncotrat Oncologia Medica Ltda [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Salvador : Nucleo de Oncologia da Bahia

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Sao Paulo : Merck Sharp & Dohme Farmaceutica Ltda.

A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)

Sao Paulo : Merck Sharp & Dohme Farmaceutica Ltda.

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

São Paulo : Hospital Santa Marcelina

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Gabrovo : MHAT Dr. Tota Venkova [Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Gabrovo : MHAT Dr. Tota Venkova [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Haskovo : Inter District Dispensery with Stationary

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Pleven : UMHAT "Dr. Georgi Stranski"

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Pleven : UMHAT ""Dr. Georgi Stranski"" Dept. Medical Oncology

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

View More »

Plovdiv : UMHAT "Sveti Georgi" [Clinic of Oncology and Hematology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Sofia : District Dispensery for Oncology Diseases with in-patient

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Sofia : District Dispensery with Stationary - Sofia District

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Sofia : SHATO - Sofia

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Sofia : UMHAT "Tsaritsa Yoanna - ISUL" Ltd.Medical Oncology Clinic

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Sofia : SHATO - Sofia

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Sofia : UMHAT "Tsaritsa Yoanna - ISUL" Ltd.Medical Oncology Clinic

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Sofia : SHATOD - Sofia City

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Sofia : District Dispensery with Stationary - Sofia District

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Sofia : Merck Sharp & Dohme IDEA Inc. Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Stara Zagora : Comprehensive Oncology Centre

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Stara Zagora : Comprehensive Oncology Centre

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Tarnovo : Inter District Oncology Dispensary with In-patient Stationar

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Varna : IDDODS "Dr. Marko Markov", Base 2 [Dept. of Medicinal Onco

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Veliko Tarnovo : Inter District Oncology Dispensary with In-patient Stationar

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Vratsa : Comprehensive Cancer Center - Vratsa

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Vratsa : Comprehensive Cancer Center - Vratsa

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kirkland : Merck Frosst Canada Ltd.

Fosaprepitant (EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030 AM1)

Santiago : Merck Sharp & Dohme (I.A.) Corp.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Bogota : Frosst Laboratories Inc.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Bogota : Frosst Laboratories Inc. Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Cakovec : Županijska bolnica Cakovec

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Osijek : Klinicki bolnicki centar [Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Osijek : Klinicki bolnicki centar Osijek [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Pula : Opca bolnica Pula [Odjel za onklologiju]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Rijeka : KBC Rijeka [Gastroenterology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

View More »

Rijeka : KBC Rijeka [Gastroenterology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Varazdin : Opca bolnica Varazdin [Odjel za hem.onko i klin.imun.]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Varazdin : Opca bolnica Varazdin [Odjel za hem.onko i klin.imun.]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Zadar : General Hospital Zadar

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Zagreb : Klinicka bolnica [Sestre milosrdnice]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Zagreb : Klinika za tumore [Odjel za kemoter. i internisticku onkolog

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Zagreb : Klinicka bolnica [Sestre milosrdnice]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Zagreb : Klinički bolnički centar Zagreb [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Mlada Boleslav : Oblastni nemocnice Mlada Boleslav a.s., Onkologie

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Nymburk : AVICENNUS s.r.o. Onkologie Nymburk

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Praha : Merck Sharp & Dohme IDEA Inc. Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Praha 5 : Fakultni nemocnice v Motole

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Praha 5 : Nemocnice Na Homolce, Oddeleni klinicke onkologie

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

View More »

Znojmo : Nemocnice Znojmo, p.o.

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Aarhus : Department of Oncology

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Copenhagen : Rigshospitalet, Finsen Centret

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Glostrup : Merck Sharp & Dohme

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Herlev : Herlev Hospital

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Odense : Department of Oncology, Odense University Hospital

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Santo Domingo : Merck Sharp & Dohme (IA) Corp.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Quito : Merck Sharp and Dohme (I.A.) Corp. Ecuador

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Espoo : MSD Finland Oy Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Courbevoie : Laboratoires Merck Sharp & Dohme - Chibret

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Augsburg : Praxis [Heinrich, Brudler, Bangerter-Haemato., Onko., Med. T

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Berlin : Medizinisches Versorgungszentrum für Hämatologie und Tumorerkrankungen, HIV/AIDS und Hepatitiden

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Berlin : Gynäkologische Arztpraxis

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Berlin : Vivantes Klinikum Neukolln

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Dresden : Universitaetsklinikum Carl Gustav Carus

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

View More »

Duisburg : St. Johannes Hospital Medizinische Klinik II, Hämatologie, Onkologie und klinische Immunologie

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Haar : Msd Sharp & Dohme Gmbh

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Hamburg : OncoResearch Lerchenfeld UG

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Hamburg : OncoResearch Lerchenfeld UG

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Hannover : Medizinische Hochschule, Zentrum für Innere Medizin, Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Hennigsdorf : Ärzteforum Hennigsdorf

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kiel : Universitatsklinikum Schleswig Holstein

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Marburg : Praxis für Innere Medizin, Hämatologie und Internistische Onkologie

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Mönchengladbach : Kliniken Maria Hilf GmbH, Krankenhaus St. Franziskus

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

München : Städtisches Klinikum [Hämato-, Onkologie + Palliativmed]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

München : Staedtisches Krankenhaus Muenchen Neuperlach

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

München : Rotkreuzklinikum [München]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

München : Städtisches Klinikum [Hämato-, Onkologie + Palliativmed]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

München : Staedtisches Krankenhaus Muenchen Neuperlach [Klinik fuer On

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Regensburg : Praxis Fuer Interdisziplinaere Onkologie und Haematologie

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Regensburg : OncoPRO GbR Dr. R. Dengler, Dr. A. Kröber Gesellschaft für klinische Studien in der ambulanten Hämatologie und Onkologie

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Tübingen : Universitätsklinikum Tübingen

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Velen : Zentrum für Onkologie

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Alimos : Vianex, S.A. / MSD

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Alimos : Vianex, S.A. / MSD Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Budapest : Országos Onkológiai Intézet [B. Belgyógyászati Osztály

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Budapest : MSD Magyarorszag Kft.

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Budapest : MSD Magyarorszag Kft.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Budapest : Semmelweis Egyetem Kútvölgyi Klinikai Tömb [Onkohaemato

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Budapest : Fővárosi Önkormányzat Uzsoki utcai Kórház

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

View More »

Budapest : Semmelweis Egyetem Kútvölgyi Klinikai Tömb [Onkohaemato

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Budapest : Fővárosi Önkormányzat Uzsoki utcai Kórház [Onkoradiol

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Budapest : MSD Magyarorszag Kft. Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Budapest : MSD Magyarorszag Kft. Updated

Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Under 18 Years of Age (MK-0517-029 AM3)

Györ : Petz Aladár Megyei Oktató Kórház [Onkoradiológiai Oszt

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Gyula : Bekes Megyei Kepviselo-testulet Pandy Kalman Korhaz [Megyei

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kecskemet : Bács-Kiskun Megyei Önkormányzat Kórháza, Szegedi

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Miskolc : Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktatók

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Miskolc : Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Nyíregyháza : Josa Andras Oktato Korhaz [Onkologiai Osztaly]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Pécs : Pécsi Tudományegyetem [Onkoterápiás Intézet]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Pécs : Pécsi Tudományegyetem [Onkoterápiás Intézet]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Szentes : Dr. Bugyi Istvan Korhaz [Oncology]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Szolnok : Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz [Onkologiai

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Szolnok : Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz [Onkologiai

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ahmedabad : M.S Patel Cancer Hospital [Oncology]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ahmedabad : Vedanta Hospital [Medical Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ahmedabad : HCG - Medi Surge Hospitals [Medical Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Amravati : Sujan Surgical Cancer Hospital and Amracvati Cancer Foundati

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Amravati : Sujan Surgical Cancer Hospital and Amracvati Cancer Foundati

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

View More »

Bangalore : Sri Venkateshwara Hospital [Medical Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Bangalore : Sri Venkateshwara Hospital [Medical Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Chennai : Dr.Rai Memorial Medical centre

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Chennai : Apollo Hospitals [Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Chennai : Apollo Hospitals [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Chennai : Dr. Kamahshi Memorial Hospital [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Cuttack : Acharya Harihara Regional Cancer Centre [Oncology]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Hubli : Research Unit, The Karnatak cancer therapy & Research Instit

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Hyderabad : Yashoda Super speciality Hospital [Medical Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Hyderabad : BIBI General Hospital & Cancer Centre [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Hyderabad : Yashoda Super speciality Hospital [Medical Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Jaipur : S.M.S College And Hospital

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kolkata : B.P.Poddar Hospital [Medical Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kolkata : Apollo Gleneagles Hospital [Clinical Trial and Research]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Lucknow : Lucknow Cancer Institute [Oncology]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Nashik : Sotabdi Super Speciality Hospital

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Pune : Ruby Hall Hospital [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Vijayawada : City Cancer Centre [Surgical and Medical Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Vijayawada : City Cancer Centre [Surgical and Medical Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Visakhapatnam : King George Hospital [Medical Oncology]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Hod Hasharon : Merck Sharp & Dohme Co. Ltd.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Brescia : Fondazione Poliambulanza Istituto Ospedaliero [U.O. di Onco

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Brescia : Fondazione Poliambulanza Istituto Ospedaliero [U.O. di Onco

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Lecce : ASL di Lecce-P.O.Vito Fazzi[U.O. di Oncologia Medica]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Lecce : ASL di Lecce-P.O.Vito Fazzi[U.O. di Oncologia Medica]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Lecco : Presidio Ospedaliero "Alessandro Manzoni"(Struttura

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

View More »

Lecco : Presidio Ospedaliero "Alessandro Manzoni"(Struttura

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Milan : Merck Sharp & Dohme (Italia) S.P.A.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Negrar : Ospedale Sacro Cuore e Don Calabria - Negrar [Oncologia Medi

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Potenza : Ospedale S.Carlo di Potenza [U.O. di Oncologia Medica]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Hidaka : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Kashihara : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Kashiwa : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Koshigaya : Research Site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Kyoto : Research

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

View More »

Maebashi : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Nagoya : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Nakagami : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Niigata : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Ota : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Sagamihara : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Sapporo : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Sayama : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Tokyo : Reseach site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Tokyo : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Yamagata : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Yokohama : Research site

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

Seoul : MSD Korea Ltd.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Seoul : Seoul St. Mary's Hospital

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Seoul : Samsung Medical Center

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)

Seoul : Kangpook Samsung Hospital

Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

Seoul : Sangye Bahk Hospital, Inje School of Medicine

Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

View More »

Seoul : Bungdang Seoul National University Hospital

Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

Seoul : Samsung Medical Center

Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

Riga : Merck Sharp & Dohme Idea Inc Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Vilnius : UAB Merck Sharp & Dohme

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Chihuahua : Centro Estatal de Oncologia de Chihuahua

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Mexico : Centro Medico Quirurgico

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.

A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)

Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

View More »

Monterrey : Centro Regiomontano de Investigación Clínica

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Haarlem : Merck Sharp & Dohme B.V.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Haarlem : Merck Sharp & Dohme B.V. Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Drammen : MSD (Norge) AS

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Drammen : MSD (Norge) AS Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Oslo : The Norwegian Radium Hospital

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin

Lima : Merck Sharp & Dohme, Peru S.R.L.

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Lima : Merck Sharp & Dohme, Peru S.R.L.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Bialystok : Bialostockie Centrum Onkologii im. M.Sklodowskiej-Curie

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Bialystok : Bialostockie Centrum Onkologii im. M.Sklodowskiej-Curie

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Elblag : Szpital Wojewodzki Zespolony

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Koscierzyna : Niepubliczny Specjalist. Onkol. Zaklad Opieki Zdrowotnej

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Lodz : Wojewodzki Szpital Specjalistyczny im. M.Kopernika

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

View More »

Lodz : Wojewodzki Szpital Specjalistyczny im. M.Kopernika

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Lomza : Szpital Wojewodzki w Lomzy im. Kardynala S. Wyszynskiego

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Lomza : Szpital Wojewodzki w Lomzy im. Kardynala S. Wyszynskiego

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Lublin : Centrum Onkologii Ziemi Lubelskiej im.Sw.Jana z Dukli

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Olsztyn : Olsztynski Osrodek Onkologiczny "KOPERNIK"

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Poznan : Ginekologiczno-Położniczy Szpital Kliniczny UM w Poznaniu

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Poznan : Wielkopolskie Centrum Onkologii im. M. Sklodowskiej-Curie

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Prabuty : Szpital Specjalistyczny

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Raciborz : Szpital Rejonowy im. dr J. Rostka w Raciborzu

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Raciborz : Szpital Rejonowy im. dr J. Rostka w Raciborzu

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Slupsk : Wojewodzki Szpital Specjalistyczny im. J. Korczaka

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Slupsk : Wojewodzki Szpital Specjalistyczny im. J. Korczaka

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Warszawa : MSD Polska Sp. z o.o. Dzial Medyczny

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Warszawa : MSD Polska Sp. z o.o. Dzial Medyczny

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Warszawa : NZOZ Magodent - Centrum Medczyne Ostrobramska

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Warszawa : Centrum Onkologii - Instytut im. Marii Sklodowskiej - Curie

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Warszawa : NZOZ Magodent - Centrum Medczyne Ostrobramska

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Warszawa : MSD Polska Sp. z o.o. Dzial Medyczny Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Paco D`arcos : Merck Sharp & Dohme Lda Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Baia-Mare : Spitalul Judetean de Urgenta "Dr. Constantin Opris" [Oncolog

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Baia-Mare : Spitalul Judetean de Urgenta "Dr. Constantin Opris" Baia-Mare [Oncologie Medicala]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Bucharest : Institutul Oncologic "Prof. Dr. Alex. Trestioreanu" [Sectia

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Bucuresti : Spitalul Universitar de Urgenta Bucuresti [Oncologie Medical

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Bucuresti : Spitalul Clinic CF nr.2 Bucuresti [Oncologie Medicala]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

View More »

Bucuresti : Institutul Oncologic "Prof. Dr. Alex. Trestioreanu" [Sectia Clinica Radioterapie II]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Bucuresti : Spitalul Universitar de Urgenta Elias [Oncologie Medicala]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Cluj-Napoca : Institutul Oncologic "Prof. Dr. Ion Chiricuta"

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Craiova : Oncolab - Oncology Center Craiova

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Iasi : Spitalul Clinic Judetean de Urgenta "Sf. Spiridon" [Oncologi

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Iasi : Centrul de Oncologie Euroclinic SRL

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Iasi : Spitalul Clinic Judetean de Urgenta "Sf. Spiridon" [Oncologi

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Onesti : Spitalul Municipal Onesti [Sectia Oncologie Medicala]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Sibiu : Spitalul Clinic Judetean de Urgenta Sibiu [Oncologie]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Tg Mures : Spitalul Clinic Judetean Mures [Clinica de Oncologie Medical

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Timisoara : Oncomed SRL

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Timisoara : Oncomed SRL

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Arkhangelsk : GUZ Arkhangelsk Regional Clinical Oncological Dispensary [Ch

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Arkhangelsk : GUZ Arkhangelsk Regional Clinical Oncological Dispensary [Ch

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Chelyabinsk : GLPU "Cheliabinsky Regional Oncology Dispensary"[Chemotherap

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ivanovo : Ivanovo Regional Oncological Dispensary [Chemotherapy]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kazan : Clinical Oncology Dispensary

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

View More »

Kazan : Clinical Oncology Dispensary [Chemotherapy]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Krasnoyarsk : GOU VPO Krasnoyarsk State Medical University n.a. prof. V.F.

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Krasnoyarsk : GOU VPO Krasnoyarsk State Medical University n.a. prof. V.F.

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Lipetsk : GUZ Lipetsk Regional Oncology Dispensary [General Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Magnitogorsk : GUZ Regional Oncology Dispensary #2

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Magnitogorsk : GUZ Regional Oncology Dispensary #2

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Moscow : Merck Sharp & Dohme IDEA, Inc.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Moscow : Russian Cancer Research Center

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Moscow : Russian Oncology Research Center n.a. N.N. Blokhin RAMN

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Moscow : SHI of Moscow City Oncology Clinical Hospital #62 [Chemotera

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Moscow : Russian Cancer Research Center

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Novgorod : Federal State Institution: Privolzhsky County Medical Center

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Novosibirsk : MBUZ City Clinical Hospital #1 [Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Novosibirsk : MBUZ City Clinical Hospital #1 [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Obninsk : Institution of RAMN "Medical Radiology Scientific Center of

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Obninsk : Institution of RAMN "Medical Radiology Scientific Center of

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Orel : Regional Oncological Dispensary [Chemotherapy]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Perm : GUZ Perm Regional Oncology Dispensary [Outpatient department

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Pyatigorsk : GUZ Pyatigorsk Oncology Dispensary [Outpatient Department]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ryazan : Ryazan State Med. Univer. n.a. I.I.Pavlov based Ryazan Regio

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Saint Petersburg : St. Petersburg Clinical Oncology Dispesary [3rd Gynecology D

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Saint Petersburg : GUZ Leningrad Regional Oncological Dispensary [Surgery Depar

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Saint Petersburg : GOU VPO Saint-Petersburg State Medical University n.a. acad.

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Saint Petersburg : St. Petersburg Clinical Oncology Dispesary [3rd Gynecology D

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Saint Petersburg : City Oncology Dispensary

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Saint-Petersburg : GOU VPO "Saint-Petersburg State Medical University

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Saint-Petersburg : GUZ "Leningrad Regional Oncology Dispensary" [mammological d

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Samara : GUZ Samara Regional Clinical Oncology Dispensary [Chemoterap

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Stavropol : Stavropol Regional Clinical Oncology Dispensary

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Tula : GUZ Tula Regional Oncological Dispensary [Oncology]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Tyumen : GUZ Leningradskiy Regional Oncology Dispensary

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ufa : Clinical Oncology Dispensary

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ufa : Clinical Oncology Dispensary [Oncology]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ufa : GUZ Republican Clinical Oncological Dispensary of public

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Beograd : Institute of oncology and radiology of Serbia

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Beograd : Clinical Hospital Center Bezanijska Kosa

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kragujevac : Clinical Center Kragujevac

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Ljubljana : Merck Sharp & Dohme Idea, Inc

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Madrid : Merck Sharp & Dohme De Espana, S.A.E.

A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)

Madrid : Merck Sharp & Dohme De Espana, S.A.E.

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Madrid : Merck Sharp & Dohme De Espana, S.A.E.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Madrid : Merck Sharp & Dohme De Espana, S.A.E. Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Madrid : Merck Sharp & Dohme De Espana, S.A.E. Updated

Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Under 18 Years of Age (MK-0517-029 AM3)

Sollentuna : Merck Sharp & Dohme (Sweden) AB

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Sollentuna : Merck Sharp & Dohme (Sweden) AB

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Sollentuna : Merck Sharp & Dohme (Sweden) AB Updated

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-induced Nausea and Vomiting (MK-0517-031 AM3)

Glattbrugg : Merck Sharp & Dohme - Chibret, A.G.

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134 AM3)

Istanbul : Merck Sharp & Dohme Ilaclari Ltd. Sti

A Study of Aprepitant (MK0869) in Pediatric Participants Undergoing Surgery (0869-148 AM1)

Istanbul : Merck Sharp & Dohme Ilaclari Ltd. Sti

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)

Cherkasy : Cherkaskyi oblasnyi onkolohichnyi dyspanser" Cherkaskoi obl

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Chernigiv : Komunalnyi likuvalno-profilaktychnyi zaklad "Chernigivskyi

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Chernivtsi : Chernivtsi Regional Cancer Hospital [Outpatient Department]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Dnipropetrovks : MBKL4,vd khimter,DDMA,kf onko i med radio [vd khimter]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Dnipropetrovks : MBKL4,vd khimter,DDMA,kf onko i med radio [vd khimter]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

View More »

Dnipropetrovsk : KZ MKL19, MOTsr, vd khimter [viddilennia khimioterapii]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Dnipropetrovsk : Komunalnyi zaklad Miska bahatoprofilna klinichna likarnia #4

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Donetsk : KKLPZ DnOPTsr [radio vd]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Donetsk : Komunalno-klinichnyi likuvalno-profilaktychnyi

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Donetsk : Komunalno-klinichnyi likuvalno-profilaktychnyi zaklad "Done

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Donetsk : Regional Oncological Hospital [Oncology/Pre-Tumor Diseases]

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kharkiv : DU IMR AMNU [vd khemter]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kharkiv : DU IMR AMNU [vd khemter]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Kharkiv : Kharkivskyi oblasnyi onkologichnyi klinichnyi tsentr

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Kharkiv : Kharkivskyi oblasnyi onkologichnyi klinichnyi tsentr

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Kyiv : KZ KOR Kyivskyi oblasnyi onkologichnyi dyspanser, [vid

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Lviv : Lvivskyi derzhavnyi onkologichnyi regionalnyi likuvalno-diag

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Odessa : Odeska oblasna klinichna likarnia

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Poltava : PoOKOD PoOR [vd khimter] VDNZ UMSA,kf onko

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Poltava : PoOKOD PoOR [vd khimter] VDNZ UMSA,kf onko

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Uzhgorod : Zakarpatskyi oblasnyi klinichnyi onkodyspanser [viddilennia

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Uzhgorod : Uzhgorod National University [Oncology]

An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting

Uzhgorod : Zakarpatskyi oblasnyi klinichnyi onkodyspanser [viddilennia

An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Zaporizhia : ZaOKOD [abdom vd]

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Hoddesdon : Merck Sharp & Dohme Ltd.

A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208 AM3)